Vacina contra poliomielite: um novo paradigma: [revisão]
Bricks, Lucia Ferro.
Rev. paul. pediatr
; 25(2): 172-179, jun. 2007. tab
Artigo em Português | LILACS, SES-SP | ID: lil-470769
Documentos relacionados
Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication.
Worst-case scenarios: Modeling uncontrolled type 2 polio transmission.
Recurring Outbreaks of Circulating Vaccine-derived Polioviruses: Implications for Global Poliovirus Immunization Strategy.
Poliovirus outbreak in New York State, August 2022: qualitative assessment of immediate public health responses and priorities for improving vaccine coverage.
Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.
Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
Time Taken to Detect and Respond to Polio Outbreaks in Africa and the Potential Impact of Direct Molecular Detection and Nanopore Sequencing.
Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3.
A circulating vaccine-derived poliovirus type 2 outbreak in a chronic conflict setting: a descriptive epidemiological study in South Sudan - 2020 to 2021.
Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance.